How small can we get?

2023: Date to be announced

BOKU Vienna, Muthgasse 11
1190 Vienna (Austria)

High Throughput Screening & Process Development – how small can we get?

Biotech industry has adopted HT screening in micro well plates as process development tools but still the major question remains on how the process can be optimised, so that it is representative of the large scale. Conversely what are the criteria for scaling-up the process developed at the microscale to large scale systems? Meanwhile technologies of even smaller dimensions such as microfluidic devices, lab-on-a chip approaches and HTPD on the nanoscale are discussed as state of the art for process development in the biotech community.
Successful application of HT systems for process development depends on the right choice of technology in combination with Design of experiment strategies or mechanistic modelling and statistical evaluation of the obtained data.

Organizing Comitee:

Astrid Dürauer

Senior Scientist BOKU Vienna

Marcel Ottens

Assoc. Professor TU Delft


Scientific Comitee:

Ana Azvedo, IST; Astrid Dürauer, BOKU Vienna; Karol Lacki, Avitide; Marcel Ottens, TU Delft; Jennifer Pollard, Merck &Co

The symposium will focus on:

Questions to be addressed:

Renowned speakers from academia and industry will give keynote lectures on the topic and will be part of a round table discussion. Researchers from academia and industry will be invited for presentations. Participants are invited to submit their work for flash presentations and poster session.

Who should attend?


Framework programme:

A site visit at Boehringer Ingelheim RCV is organized on Tuesday morning (max. 25 participants, first come first serve) including a short introduction of the company and a guided tour to the automation lab at the Process Bioscience Division where a HT platform for process development of E.coli derived products has been set up in collaboration with BOKU Vienna.

Social Programme:

A get together will be organized at a typical Viennese Heurigen.

Registration & Abstract submission


Includes registration fee, welcome reception, dinner at Heurigen, all coffee and lunch breaks during the symposium. Please stay tuned, more information will come soon …

Abstract submission

Please stay tuned, more information will come soon …

Speakers (confirmed)

Sandra Abad Unit Lead Upstream Development at Boehringer Ingelheim RCV, Austria
Ana Azevedo Ass. Professor at Instituto Superior Técnico, Portugal
Cécile Brocard Director Downstream Development at Boehringer Ingelheim RCV, Austria
Mark Dürkop CEO at Novasign GmbH, Austria
Rainer Hahn Assoc. Professor at BOKU Vienna, Austria
Alois Jungbauer Professor at BOKU Vienna, Austria
Karol Lacki Vice President of Technology Development at Avitide, USA
Michael Melcher Scientist at BOKU Vienna, Austria
Marco Marques Lecturer at UCL, UK
Martina Micheletti Senior Scientist UCL, UK
Peter Neubauer Professor at TU Berlin, Germany
Bernt Nilsson Professor at Lund University, Sweden
Jennifer Pollard Process Development and Engineering, Merck & Co, USA
Susanne Schweiger R&D Croma-Pharma, Austria
Gerald Striedner Assoc. Professor at BOKU Vienna, Austria
Nicolas Szita Professor at UCL, UK
Shuichi Yamamoto Professor at Yamaguchi University, Japan